Journal article
Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists
Diagnostic microbiology and infectious disease, Vol.75(3), pp.256-259
03/2013
DOI: 10.1016/j.diagmicrobio.2012.11.020
PMCID: PMC5815827
PMID: 23305775
Abstract
Antimicrobial shortages have made treating certain infections more difficult. A web-based survey asking about experience with antimicrobial drug shortages was distributed in 2011 to 1328 infectious diseases physician members of the Emerging Infectious Diseases Network of the Infectious Diseases Society of America. A majority (78%) of 627 respondents reported needing to modify antimicrobial choices because of drug shortages within the past 2 years. Antimicrobials most often reported as not available or available but in short supply were trimethoprim–sulfamethoxazole injection (by 65% of respondents), amikacin (by 58%), aztreonam (by 31%), and foscarnet (by 22%). Most respondents (55%) reporting a shortage indicated that the shortage adversely affected patient outcomes and that they were forced to use alternative and second line agents which were either less effective, more toxic, or more costly. Most (70%) indicated that they learned about the shortage from contact with the pharmacy after trying to prescribe a drug in short supply. More effective means of informing physicians about drug shortages is critical to lessen the impact on patient care.
Details
- Title: Subtitle
- Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists
- Creators
- Adi V. Gundlapalli - University of UtahSusan E. Beekmann - University of IowaDonald R. Graham - Springfield ClinicPhilip M. Polgreen - University of IowaInfectious Diseases Society of America's Emerging Infections Network
- Resource Type
- Journal article
- Publication Details
- Diagnostic microbiology and infectious disease, Vol.75(3), pp.256-259
- DOI
- 10.1016/j.diagmicrobio.2012.11.020
- PMID
- 23305775
- PMCID
- PMC5815827
- NLM abbreviation
- Diagn Microbiol Infect Dis
- ISSN
- 0732-8893
- eISSN
- 1879-0070
- Publisher
- Elsevier Inc
- Grant note
- DOI: 10.13039/100000030, name: Centers for Disease Control and Prevention, award: U50 CCU112346; name: Utah CDC Rocky Mountain Center for Translational Research in Public Health Informatics, award: 5P01HK000069; name: NIH Rocky Mountain Regional Center of Excellence for Emerging Infections, award: 1 U54 A1065357
- Language
- English
- Date published
- 03/2013
- Academic Unit
- Infectious Diseases; Epidemiology; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984359577702771
Metrics
17 Record Views